These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 2414994
1. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE. Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994 [Abstract] [Full Text] [Related]
2. Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Moll R. Acta Histochem Suppl; 1991 Nov; 41():117-27. PubMed ID: 1725827 [Abstract] [Full Text] [Related]
3. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. LaRocca PJ, Rheinwald JG. Cancer Res; 1984 Jul; 44(7):2991-9. PubMed ID: 6202404 [Abstract] [Full Text] [Related]
4. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Warhol MJ, Hickey WF, Corson JM. Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872 [Abstract] [Full Text] [Related]
5. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Lee I, Radosevich JA, Chejfec G, Ma YX, Warren WH, Rosen ST, Gould VE. Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302 [Abstract] [Full Text] [Related]
6. Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Moll R, Levy R, Czernobilsky B, Hohlweg-Majert P, Dallenbach-Hellweg G, Franke WW. Lab Invest; 1983 Nov; 49(5):599-610. PubMed ID: 6195450 [Abstract] [Full Text] [Related]
7. [Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin]. Beham A, Ratschek M, Zatloukal K, Denk H, Lackinger E. Verh Dtsch Ges Pathol; 1989 Nov; 73():392-5. PubMed ID: 2482624 [Abstract] [Full Text] [Related]
15. [Intermediate filament patterns of the nephron and the urothelium]. Moll R. Verh Dtsch Ges Pathol; 1989 Jan; 73():314-20. PubMed ID: 2482617 [Abstract] [Full Text] [Related]
16. Diagnostic significance of coexpression of intermediate filaments in fine needle aspirates of human tumors. Domagala W, Weber K, Osborn M. Acta Cytol; 1988 Jan; 32(1):49-59. PubMed ID: 2447723 [Abstract] [Full Text] [Related]
17. Intermediate filament proteins in asbestos-induced mesotheliomas of the rat. Mackay AM, Tracy RP, Craighead JE. Cancer Res; 1987 Oct 15; 47(20):5461-8. PubMed ID: 2443239 [Abstract] [Full Text] [Related]
18. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT, Gentile P, Tarectecan A, Fuchs A. Arch Pathol Lab Med; 1996 Oct 15; 120(10):959-66. PubMed ID: 12046609 [Abstract] [Full Text] [Related]
19. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. Dewar A, Valente M, Ring NP, Corrin B. J Pathol; 1987 Aug 15; 152(4):309-16. PubMed ID: 3668733 [Abstract] [Full Text] [Related]
20. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas. Popper H, Wirnsberger G, Hoefler H, Denk H. Cancer Detect Prev; 1987 Aug 15; 10(3-4):167-74. PubMed ID: 2436780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]